Oct 1 |
LabCorp started at neutral by Piper Sandler, price run up cited
|
Oct 1 |
Meta, Alphabet initiated: Wall Street's top analyst calls
|
Sep 25 |
Should You Continue to Retain LH Stock in Your Portfolio?
|
Sep 24 |
Labcorp to Announce Third Quarter Financial Results on October 24, 2024
|
Sep 24 |
LH Stock Likely to Gain From the Molecular Bioanalytical Lab Expansion
|
Sep 20 |
Analyst Ratings For Labcorp Holdings
|
Sep 18 |
Ovia Health Expands Women's Health Offerings with Comprehensive Postpartum Experience
|
Sep 17 |
Labcorp Stock Gains From Its Latest Acquisition of BioReference Health
|
Sep 17 |
Labcorp subsidiary prices $2B notes offering
|
Sep 16 |
LABCORP PRICES $650,000,000 IN 4.350% SENIOR NOTES DUE 2030, $500,000,000 IN 4.550% SENIOR NOTES DUE 2032 AND $850,000,000 IN 4.800% SENIOR NOTES DUE 2034
|